Work

Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia

Year: 2012

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.3109/10428194.2012.658794

Authors: Michael Doubek, Martin Trbušek, Jitka Malčíková, Yvona Brychtová, Jana Šmardová, Jana Lochmanová, Anna Panovská, Hana Skuhrová Francová, Marek Mráz, Boris Tichý, Ludmila Šebejová, Veronika Navrkalová, Karla Plevová, Petr Kuglík, Jiří Mayer, Šárka Pospíšilová

Institutions: Central European Institute of Technology, Central European Institute of Technology, Masaryk University, University Hospital Brno

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2002106296

FWCI: 0.278

Cites: 11

Cited by: 3

Related to: 10